MedPath

The Effect of Adalimumab on the Bone Microstructure in Crohn's Disease (CD) Patients

Terminated
Conditions
Crohn's Disease
Registration Number
NCT01012570
Lead Sponsor
Gerhard Rogler
Brief Summary

The investigators will study the effect of Adalimumab on the bone microstructure.

* Trial with medicinal product

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
34
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath